These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 26339563)
61. The multi-biomarker disease activity score tracks response to rituximab treatment in rheumatoid arthritis patients: a post hoc analysis of three cohort studies. Roodenrijs NMT; de Hair MJH; Wheater G; Elshahaly M; Tekstra J; Teng YKO; Lafeber FPJG; Hwang CC; Liu X; Sasso EH; van Laar JM Arthritis Res Ther; 2018 Nov; 20(1):256. PubMed ID: 30458871 [TBL] [Abstract][Full Text] [Related]
62. Discrepancies in assessment of patients with rheumatoid arthritis and secondary Sjögren's syndrome by DAS28-ESR and DAS28-CRP. Romanowska-Próchnicka K; Olesińska M; Paradowska-Gorycka A; Mańczak M; Felis-Giemza A; Wojdasiewicz P; Szukiewicz D Cent Eur J Immunol; 2016; 41(2):188-94. PubMed ID: 27536205 [TBL] [Abstract][Full Text] [Related]
63. Patient self-report outcomes to guide a treat-to-target strategy in clinical trials and usual clinical care of rheumatoid arthritis. Castrejón I; Pincus T Clin Exp Rheumatol; 2012; 30(4 Suppl 73):S50-5. PubMed ID: 23079199 [TBL] [Abstract][Full Text] [Related]
72. Psychometric properties of MDHAQ/RAPID3 in patients with systemic lupus erythematosus. Annapureddy N; Giangreco D; Devilliers H; Block JA; Jolly M Lupus; 2018 May; 27(6):982-990. PubMed ID: 29451066 [TBL] [Abstract][Full Text] [Related]
73. Patient-reported outcomes in ANCA-associated vasculitis. A comparison between Birmingham Vasculitis Activity Score and routine assessment of patient index data 3. Annapureddy N; Elsallabi O; Baker J; Sreih AG Clin Rheumatol; 2016 Feb; 35(2):395-400. PubMed ID: 25822996 [TBL] [Abstract][Full Text] [Related]
74. Lower education and living in countries with lower wealth are associated with higher disease activity in rheumatoid arthritis: results from the multinational COMORA study. Putrik P; Ramiro S; Keszei AP; Hmamouchi I; Dougados M; Uhlig T; Kvien TK; Boonen A Ann Rheum Dis; 2016 Mar; 75(3):540-6. PubMed ID: 25630346 [TBL] [Abstract][Full Text] [Related]
75. Evaluation of disease activity in patients with rheumatoid arthritis treated with tofacitinib by RAPID3: post hoc analyses from two phase 3 trials. Strand V; Lee EB; Yazici Y; Dikranian A; Wilkinson B; Takiya L; Zang C; Bananis E; Bergman MJ Clin Rheumatol; 2018 Aug; 37(8):2043-2053. PubMed ID: 29656373 [TBL] [Abstract][Full Text] [Related]
76. Ten years of change in clinical disease status and treatment in rheumatoid arthritis: results based on standardized monitoring of patients in an ordinary outpatient clinic in southern Norway. Haugeberg G; Hansen IJ; Soldal DM; Sokka T Arthritis Res Ther; 2015 Aug; 17(1):219. PubMed ID: 26290061 [TBL] [Abstract][Full Text] [Related]
77. Defining criteria for rheumatoid arthritis patient-derived disease activity score that correspond to Disease Activity Score 28 and Clinical Disease Activity Index based disease states and response criteria. Leung AM; Farewell D; Lau CS; Choy EH Rheumatology (Oxford); 2016 Nov; 55(11):1954-1958. PubMed ID: 27477805 [TBL] [Abstract][Full Text] [Related]
78. Correlation of rheumatoid arthritis activity indexes (Disease Activity Score 28 measured with ESR and CRP, Simplified Disease Activity Index and Clinical Disease Activity Index) and agreement of disease activity states with various cut-off points in a Northeastern Brazilian population. Medeiros MM; de Oliveira BM; de Cerqueira JV; Quixadá RT; de Oliveira ÍM Rev Bras Reumatol; 2015; 55(6):477-84. PubMed ID: 25772662 [TBL] [Abstract][Full Text] [Related]
79. Evaluation of the activity of rheumatoid arthritis in clinical practice. Agreement between self-rated clinimetric evaluation and clinical evaluation with activity indexes: DAS28, CDAI and SDAI. Horta-Baas G; Pérez Bolde-Hernández A; Hernández-Cabrera MF; Vergara-Sánchez I; Romero-Figueroa MDS Med Clin (Barc); 2017 Oct; 149(7):293-299. PubMed ID: 28408110 [TBL] [Abstract][Full Text] [Related]
80. Rituximab therapy in patients with rheumatoid arthritis refractory or with contraindication to anti-tumour necrosis factor drugs: real-life experience in Finnish patients. Valleala H; Korpela M; Möttönen T; Hienonen-Kempas T; Kauppi M; Hannonen P; Leirisalo-Repo M Scand J Rheumatol; 2009; 38(5):323-7. PubMed ID: 19585384 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]